Kenza Health Hub logoGet Started
1 May 2026Oral drugsSource update: August 2022

Ethambutol = E oral

Ethambutol guidance for tuberculosis combination therapy, with optic neuritis monitoring precautions.

Prescription under medical supervision
This guide page is for structured reference only and does not replace a clinician, pharmacist, or emergency review. Dose choice, route choice, interactions, and safety decisions still need professional judgment.

Therapeutic action

First-line antituberculosis antibacterial (bacteriostatic activity).

Indications

Tuberculosis, in combination with other antituberculosis antibacterials.

Forms and strengths

  • 100 mg and 400 mg tablets.
  • 50 mg and 100 mg dispersible tablets.

Dose

  • Child and adult: 15 to 25 mg/kg once daily.
  • Do not exceed 1200 mg daily.
  • Patient with renal impairment: 15 to 25 mg/kg 3 times weekly.

Duration

According to protocol.

Contra-indications, adverse effects, precautions

  • Do not administer to patients with severe renal impairment or pre-existing optic neuritis such as diabetic retinopathy.
  • May cause dose-related retrobulbar optic neuritis, worsened by renal impairment.
  • Patients should immediately stop treatment and seek medical attention in the event of visual disturbances such as blurred vision, reduced visual acuity, or green-red colour blindness.
  • Visual alterations are usually reversible a few weeks after stopping ethambutol.
  • Dosage must be carefully adjusted to body weight, especially for children under 5 years because visual alterations are harder to detect.
  • Pregnancy: no contra-indication.
  • Breast-feeding: no contra-indication.

Source

MSF Essential drugs practical guidelines (January 2026)

This page reproduces the structured reference information for this batch while leaving out the Storage and Remarks sections.

Rate this guide

Be the first to rate this guide.